533543 Stock Overview
Manufactures and sells pharmaceuticals in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Brooks Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹145.05 |
| 52 Week High | ₹185.15 |
| 52 Week Low | ₹72.51 |
| Beta | 1.49 |
| 11 Month Change | -0.99% |
| 3 Month Change | 33.16% |
| 1 Year Change | 26.52% |
| 33 Year Change | 23.50% |
| 5 Year Change | 343.58% |
| Change since IPO | 140.95% |
Recent News & Updates
Recent updates
Shareholder Returns
| 533543 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | 9.2% | 1.1% | 1.8% |
| 1Y | 26.5% | 55.7% | 36.8% |
Return vs Industry: 533543 underperformed the Indian Life Sciences industry which returned 55.7% over the past year.
Return vs Market: 533543 underperformed the Indian Market which returned 36.8% over the past year.
Price Volatility
| 533543 volatility | |
|---|---|
| 533543 Average Weekly Movement | 8.1% |
| Life Sciences Industry Average Movement | 6.5% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: 533543's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 533543's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 293 | n/a | www.brookslabs.net |
Brooks Laboratories Limited manufactures and sells pharmaceuticals in India and internationally. The company offers liquid and dry powder injection, carbapenem dry powder injectables, tablets, oral suspension, dry syrup, and eye/ear drops. Brooks Laboratories Limited was incorporated in 2002 and is based in Mumbai, India.
Brooks Laboratories Limited Fundamentals Summary
| 533543 fundamental statistics | |
|---|---|
| Market cap | ₹3.82b |
| Earnings (TTM) | -₹175.35m |
| Revenue (TTM) | ₹817.16m |
4.7x
P/S Ratio-21.8x
P/E RatioIs 533543 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 533543 income statement (TTM) | |
|---|---|
| Revenue | ₹817.16m |
| Cost of Revenue | ₹579.34m |
| Gross Profit | ₹237.83m |
| Other Expenses | ₹413.18m |
| Earnings | -₹175.35m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -6.68 |
| Gross Margin | 29.10% |
| Net Profit Margin | -21.46% |
| Debt/Equity Ratio | 8.6% |
How did 533543 perform over the long term?
See historical performance and comparison